Literature DB >> 6886998

Estimating the accumulation of drugs.

W A Colburn.   

Abstract

Mesh：

Substances：

Year:  1983        PMID： 6886998     DOI： 10.1002/jps.2600720734

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN： 0022-3549            Impact factor:   3.534


× No keyword cloud information.
  22 in total

Review 1.  Rate and extent of drug accumulation after multiple dosing revisited.

Authors:  Dion R Brocks; Reza Mehvar
Journal:  Clin Pharmacokinet       Date:  2010-07       Impact factor: 6.447

2.  Phase I study of multiple-dose cefprozil and comparison with cefaclor.

Authors:  R H Barbhaiya; U A Shukla; C R Gleason; W C Shyu; R B Wilber; R R Martin; K A Pittman
Journal:  Antimicrob Agents Chemother       Date:  1990-06       Impact factor: 5.191

3.  Evaluation of a Cmin and a normalized Cmin method for the confirmation of steady-state in bioequivalence studies.

Authors:  A J Jackson
Journal:  Pharm Res       Date:  1998-07       Impact factor: 4.200

4.  Plasma tenoxicam concentrations after single and multiple oral doses.

Authors:  C Crevoisier; P Heizmann; I Forgo; U C Dubach
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1989 Jan-Mar       Impact factor: 2.441

5.  Urinary excretion of cimetropium bromide after multiple oral doses.

Authors:  B P Imbimbo; A Piperno; G Fiorelli; F Muzio; S Daniotti
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

6.  Pharmacokinetics of mifentidine after single and multiple oral administration to healthy volunteers.

Authors:  B P Imbimbo; R Urso; G Thieme; B Sturn; B Ueckert; A Vidi; H Ladinsky; S Daniotti
Journal:  Br J Clin Pharmacol       Date:  1988-10       Impact factor: 4.335

7.  Pharmacokinetics of cefpodoxime in plasma and skin blister fluid following oral dosing of cefpodoxime proxetil.

Authors:  M T Borin; G S Hughes; C R Spillers; R K Patel
Journal:  Antimicrob Agents Chemother       Date:  1990-06       Impact factor: 5.191

8.  The pharmacokinetics of teniloxazine in healthy subjects and patients with hepatic cirrhosis.

Authors:  R Orlando; C Benvenuti; M Mazzo; P Palatini
Journal:  Br J Clin Pharmacol       Date:  1995-04       Impact factor: 4.335

9.  Pharmacokinetics of co-administered didanosine and stavudine in HIV-seropositive male patients.

Authors:  R D Seifert; M B Stewart; J J Sramek; J Conrad; S Kaul; N R Cutler
Journal:  Br J Clin Pharmacol       Date:  1994-11       Impact factor: 4.335

10.  Pharmacokinetics and protein binding of ceftriaxone during pregnancy.

Authors:  P Bourget; H Fernandez; V Quinquis; C Delouis
Journal:  Antimicrob Agents Chemother       Date:  1993-01       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.